Forced Homodimerization by Site-Directed Mutagenesis Alters Guanylyl Cyclase Activity of Natriuretic Peptide Receptor B

Abstract—Natriuretic peptides mediate their physiologic effects through activation of membrane-bound, guanylyl cyclase–coupled receptors (NPRs). Receptor dimerization is an important feature of signal transduction. This study was aimed at characterizing structurally important residues of the extracellular ligand-binding domain of NPR-B for receptor dimerization and cGMP generation. Deletion mutagenesis was used to replace cysteine residues at positions 53 (C53S), 417 (C417S), and 426 (C426S) by serine. Receptor expression, dimerization, whole-cell cGMP response, and guanylyl cyclase activity of membrane fractions were determined in stably transfected COS-7 cells. C53S, C417S, and C426S mutants were expressed and found to form disulfide-bridged covalent dimers. In contrast to NPR-B and C53S, C417S and C426S mutants displayed constitutive activity in whole cells (C417S, 146±12%, P <0.01; C426S, 153±7% of ligand-independent NPR-B cGMP generation, P <0.01). The cGMP response of C417S and C426S mutants in whole cells was dose dependent and ≈4 times lower than that in NPR-B, whereas it was blunted in C53S-transfected cells (1 &mgr;mol/L CNP, NPR-B 2868±436%; C53S, 206±16% of control, P <0.001 vs NPR-B, C417S, and C426S). Guanylyl cyclase assay in transfected cells confirmed the constitutive activity of C417S and C426S mutants. These data suggest that receptor dimerization by covalent disulfide bridges alters ligand-independent as well as ligand-dependent receptor activity. Localization of the crosslink in relation to the cell membrane is important for configuration of the extracellular domain and the consecutive signal transduction.

[1]  J. Labrecque,et al.  Natriuretic Peptide Receptor A Activation Stabilizes a Membrane-distal Dimer Interface* , 2003, The Journal of Biological Chemistry.

[2]  J. Labrecque,et al.  Reduced activity of the NPR-A kinase triggers dephosphorylation and homologous desensitization of the receptor. , 2001, Biochemistry.

[3]  J. Labrecque,et al.  Agonistic Induction of a Covalent Dimer in a Mutant of Natriuretic Peptide Receptor-A Documents a Juxtamembrane Interaction That Accompanies Receptor Activation* , 2001, The Journal of Biological Chemistry.

[4]  T. Hunter,et al.  Guanylyl Cyclase-linked Natriuretic Peptide Receptors: Structure and Regulation* , 2001, The Journal of Biological Chemistry.

[5]  T. Hunter,et al.  Activation of Protein Kinase C Stimulates the Dephosphorylation of Natriuretic Peptide Receptor-B at a Single Serine Residue , 2000, The Journal of Biological Chemistry.

[6]  M. Miyagi,et al.  Structure of the dimerized hormone-binding domain of a guanylyl- cyclase-coupled receptor , 2000, Nature.

[7]  M. Miyagi,et al.  Disulfide bond structure of the atrial natriuretic peptide receptor extracellular domain: conserved disulfide bonds among guanylate cyclase-coupled receptors. , 2000, Biochimica et biophysica acta.

[8]  K. Misono,et al.  Ligand binding-dependent limited proteolysis of the atrial natriuretic peptide receptor: juxtamembrane hinge structure essential for transmembrane signal transduction. , 1999, Biochemistry.

[9]  M. Marquis,et al.  A Disulfide-bridged Mutant of Natriuretic Peptide Receptor-A Displays Constitutive Activity , 1999, The Journal of Biological Chemistry.

[10]  T. Nakayama,et al.  Structure of the type B human natriuretic peptide receptor gene and association of a novel microsatellite polymorphism with essential hypertension. , 1999, Circulation research.

[11]  W. Forssmann,et al.  The endocrine heart and natriuretic peptides: histochemistry, cell biology, and functional aspects of the renal urodilatin system , 1998, Histochemistry and Cell Biology.

[12]  T. Hunter,et al.  Phosphorylation of the Kinase Homology Domain Is Essential for Activation of the A-Type Natriuretic Peptide Receptor , 1998, Molecular and Cellular Biology.

[13]  P. Trindade,et al.  Mechanisms of natriuretic-peptide-induced growth inhibition of vascular smooth muscle cells. , 1997, Cardiovascular research.

[14]  T. Maack.  Role of atrial natriuretic factor in volume control. , 1996, Kidney international.

[15]  D. Garbers,et al.  Guanylyl cyclase receptors. , 1994, The Journal of biological chemistry.

[16]  D. Lowe.  Human natriuretic peptide receptor-A guanylyl cyclase is self-associated prior to hormone binding. , 1992, Biochemistry.

[17]  D. Garbers.  Guanylyl cyclase receptors and their endocrine, paracrine, and autocrine ligands , 1992, Cell.

[18]  L. Gooding.  Virus proteins that counteract host immune defenses , 1992, Cell.

[19]  K. Hosoda,et al.  Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. , 1992, Endocrinology.

[20]  T. Ito,et al.  Bifunctional atrial natriuretic peptide receptor (type A) exists as a disulfide-linked tetramer in plasma membranes of bovine adrenal cortex. , 1991, Journal of biochemistry.

[21]  B. Brenner,et al.  Diverse biological actions of atrial natriuretic peptide. , 1990, Physiological reviews.

[22]  Michael Chinkers,et al.  The protein kinase domain of the ANP receptor is required for signaling. , 1989, Science.